Cargando…

Relationship between the agonist activity of synthetic ligands of TRAIL-R2 and their cell surface binding modes

Tumor Necrosis Factor Receptor Apoptosis Inducing Ligand (TRAIL) appears as an interesting candidate for targeted cancer therapy as it induces apoptosis in cancer cells without toxicity to normal cells. TRAIL elicits apoptosis through agonist death receptor TRAIL-R1 and TRAIL-R2 engagement. Neverthe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chekkat, Neila, Lombardo, Caterina M., Seguin, Cendrine, Lechner, Marie-Charlotte, Dufour, Florent, Nominé, Yves, De Giorgi, Marcella, Frisch, Benoit, Micheau, Olivier, Guichard, Gilles, Altschuh, Danièle, Fournel, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884648/
https://www.ncbi.nlm.nih.gov/pubmed/29643993
http://dx.doi.org/10.18632/oncotarget.24526